Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CELLULAR TECHNICAL SERVICES CO INC | 674,708 | reported | 13 May 2019 | tx 134+9,052,954−4,009,471 |
| TRANS1 INC | 229,571 | reported | 31 May 2013 | tx 25+691,577 |
| Replimune Group, Inc. | 32,000 | reported | 01 Apr 2025 | tx 12+185,316−10,400 |
| CVRx, Inc. | 19,554 | reported | 03 Jun 2025 | tx 45+156,889−16,590 |
| ImageneBio, Inc. | 16,000 | reported | 24 Dec 2025 | tx 2+47,200 |
| CANCERVAX CORP | 0 | reported | 07 Mar 2012 | tx 13+135,148−133,383 |
| DIGENE CORP | 0 | reported | 20 Nov 2006 | tx 121+268,749−344,998 |
| Morphic Holding, Inc. | 0 | reported | 16 Aug 2024 | tx 15+95,935−107,934 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Dec 2025 | PURCHASE | ImageneBio, Inc. | 16,000 | 5.99 USD | first after silence |
| 18 Dec 2025 | GRANT_AWARD | ImageneBio, Inc. | 31,200 | 0.00 USD | deriv |
| 03 Jun 2025 | GRANT_AWARD | CVRx, Inc. | 19,554 | 0.00 USD | deriv |
| 01 Apr 2025 | GRANT_AWARD | Replimune Group, Inc. | 32,000 | 0.00 USD | deriv |
| 16 Aug 2024 | OTHER | Morphic Holding, Inc. | 9,066 | — | |
| 16 Aug 2024 | OTHER | Morphic Holding, Inc. | 23,168 | — | deriv |
| 16 Aug 2024 | OTHER | Morphic Holding, Inc. | 12,535 | — | deriv |
| 16 Aug 2024 | OTHER | Morphic Holding, Inc. | 17,550 | — | deriv |
| 16 Aug 2024 | OTHER | Morphic Holding, Inc. | 9,615 | — | deriv |
| 16 Aug 2024 | OTHER | Morphic Holding, Inc. | 12,000 | — | deriv |
| 16 Aug 2024 | OTHER | Morphic Holding, Inc. | 24,000 | — | deriv |
| 15 Aug 2024 | PURCHASE | CVRx, Inc. | 3,000 | 8.10 USD | |
| 08 Aug 2024 | PURCHASE | CVRx, Inc. | 3,000 | 8.24 USD | |
| 06 Aug 2024 | PURCHASE | CVRx, Inc. | 2,500 | 9.09 USD | |
| 04 Jun 2024 | GRANT_AWARD | CVRx, Inc. | 20,961 | 0.00 USD | deriv |
| 04 Jun 2024 | GRANT_AWARD | Morphic Holding, Inc. | 23,168 | 0.00 USD | deriv |
| 01 Apr 2024 | GRANT_AWARD | Replimune Group, Inc. | 32,000 | 0.00 USD | deriv |
| 28 Dec 2023 | EXERCISE | CVRx, Inc. | 1,456 | 0.24 USD | |
| 28 Dec 2023 | EXERCISE | CVRx, Inc. | 96 | 3.96 USD | |
| 28 Dec 2023 | EXERCISE | CVRx, Inc. | 224 | 0.24 USD | |
| 28 Dec 2023 | EXERCISE | CVRx, Inc. | 174 | 1.19 USD | |
| 28 Dec 2023 | EXERCISE | CVRx, Inc. | 96 | 0.00 USD | deriv |
| 28 Dec 2023 | EXERCISE | CVRx, Inc. | 174 | 0.00 USD | deriv |
| 28 Dec 2023 | EXERCISE | CVRx, Inc. | 1,456 | 0.00 USD | deriv |
| 28 Dec 2023 | EXERCISE | CVRx, Inc. | 224 | 0.00 USD | deriv |
5 purchases reported after at least 12 months of silence — most recent on 24 Dec 2025.